Add-On ZIDA Sock Therapy for Overactive Bladder
RecruitingNCT07432659Phase: NAStarted 2026-04-17
Summary
Many people with overactive bladder (OAB) continue to experience symptoms despite pharmacologic treatment. This study evaluates the use of the ZIDA Control Sock, an FDA-cleared, noninvasive wearable d
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Rutledge Tower at Medical University of South CarolinaCharleston, South Carolina, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07432659